Eli Lilly and CompanyLLYNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+12.2%
5Y CAGR+3.4%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+12.2%/yr
vs +4.2%/yr prior
5Y CAGR
+3.4%/yr
Recent acceleration
Acceleration
+8.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 42.86% | +26.8% |
| 2024 | 33.81% | +34.6% |
| 2023 | 25.11% | -17.3% |
| 2022 | 30.34% | +6.8% |
| 2021 | 28.40% | -21.8% |
| 2020 | 36.32% | +17.5% |
| 2019 | 30.91% | +20.1% |
| 2018 | 25.74% | +25.5% |
| 2017 | 20.51% | -13.9% |
| 2016 | 23.82% | - |